International Normalized Ratio-to-Albumin Ratio as a Novel Marker of Upper Gastrointestinal Bleeding Severity

Choi, Jeongwoo; Lee, Je Seop; Lee, Solmoon; Kim, Yong Won; Lee, Yoonsuk; Kim, Tae Youn

doi:https://doi.org/10.1155/2022/1172540

Gastroenterology Research and Practice

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 1172540 | https://doi.org/10.1155/2022/1172540

International Normalized Ratio-to-Albumin Ratio as a Novel Marker of Upper Gastrointestinal Bleeding Severity

Jeongwoo Choi,¹Je Seop Lee,¹Solmoon Lee,¹Yong Won Kim,²Yoonsuk Lee,^1,3and Tae Youn Kim²

Academic Editor: Duc Trong Quach

Received19 May 2022

Revised15 Aug 2022

Accepted29 Sept 2022

Published13 Oct 2022

Abstract

Introduction. Upper gastrointestinal bleeding (UGIB) is a potentially life-threatening gastrointestinal emergency, and effective management depends on early risk stratification. The Glasgow–Blatchford and Rockall scores are commonly used prognostic measures for UGIB, although these scoring systems are relatively difficult to apply in early emergency settings. AIMS65 with five items, albumin, international normalized ratio, mental status, systolic blood pressure, and age (>65 years), showed efficacy in predicting long-term hospitalization and mortality. This study aimed to investigate the usefulness of the prothrombin time-international normalized ratio-to-albumin ratio (PTAR) in the emergency room for early UGIB risk stratification. Methods. We retrospectively examined patients who visited a tertiary academic hospital’s emergency department (ED) with UGIB as the chief presentation between January 2019 and December 2020. The cutoff values and diagnostic accuracies of the PTAR, Glasgow–Blatchford score, AIMS65 score, pre-endoscopy, and complete Rockall score were analyzed, and the performance of the PTAR was compared with that of other risk stratification methods. In total, 519 patients were enrolled: 163 patients were admitted in the intensive care unit (ICU) and 35 died during admission. Multiple logistic regression analyses confirmed the association of the PTAR with ICU admission and mortality. The adjusted odd ratio (aOR) of the PTAR for ICU admission care was 8.376 (2.722–25.774), and the aOR of the PTAR for mortality was 27.846 (8.701–89.116). Conclusions. The PTAR measured in the ED is an independent factor related to ICU admission and mortality in patients with UGIB. Using ED blood laboratory results, which are reported relatively quickly and are easy to acquire and calculate, the PTAR can be used as a risk stratification marker in the early emergency setting.

1. Introduction

Upper gastrointestinal bleeding (UGIB) requires frequent hospitalizations and carries substantial morbidity and mortality risks. In the United States, UGIB incurs over $1 billion in direct medical costs annually [1, 2]. UGIB is a potentially life-threatening gastrointestinal emergency, and early risk stratification can be useful to determine effective management [3]. The Glasgow–Blatchford Score (GBS), Rockall score, and albumin, international normalized ratio, mental status, systolic blood pressure, age>65 years (AIMS65) score are prognostic tools for UGIB [4]. However, they are challenging to apply in the emergency setting, as they require various laboratory and clinical variables, including endoscopy, to predict prognosis [5].

Laboratory tests for UGIB have been used in various ways to predict prognosis [6, 7]. In particular, complete blood count and chemistry results have been used for early prognostic prediction in the emergency department (ED) [8, 9]. A new objective liver function score model called the prothrombin time-international normalized ratio (PT-INR)-to-albumin ratio (PTAR) has been used for risk stratification in hepatic cellular carcinoma and sepsis [8, 10]. Decreased liver function is associated with mortality and morbidity in patients with UGIB [11]; thus, it is recommended to measure liver function in the ED [12]. The PTAR may be a potentially useful marker for assessing liver function in patients with UGIB. This study aimed to investigate the usefulness of the PTAR measured in the ED and compare it to other risk stratification methods (e.g., AIMS65, Rockall score, and GBS) for UGIB.

2. Materials and Methods

2.1. Study Design and Participants

This retrospective observational study was performed at the ED of a tertiary university hospital which accommodates 43,000 patients annually, approximately 250 of whom present with UGIB. This study was approved by the Institutional Review Board of Wonju Severance Christian Hospital (IRB No. CR321093). The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki, and the requirement for written informed consent was waived owing to the retrospective nature of the study.

In total, 520 patients, who visited the ED with UGIB as the chief presentation between January 2019 and December 2020, were evaluated. Patients with UGIB as a discharge code in the computerized hospital records were eligible for inclusion in this study. The exclusion criteria were age <19 years.

2.2. Study Variables

Data were retrospectively collected from the electronic medical records. These included age, sex, intensive care unit (ICU) admission, and mortality. Systolic blood pressure, pulse rate, hemoglobin, platelet count, blood urea nitrogen, creatinine, PT-INR, and albumin levels measured within 1 hour of ED arrival were also analyzed. Comorbidities include hypertension, diabetes mellitus, liver cirrhosis, chronic renal failure, and heart failure. The PTAR was measured in the ED using serum laboratory parameters. Both the pre-endoscopy and complete Rockall scores were retrospectively calculated. The pre-endoscopy Rockall score is calculated using age; presence of shock; presence of comorbidities such as cardiac failure, ischemic heart disease, renal, or liver failure; and disseminated malignancy. Post-endoscopy diagnosis and major stigmata are added to the pre-endoscopy Rockall score to calculate the complete Rockall score [13]. Meanwhile, the Glasgow–Blatchford score included the heart rate, systolic blood pressure, blood urea nitrogen, and hemoglobin level [14, 15]. The AIMS65 score was calculated by allotting 1 point each for albumin level <30 g/L, INR >1.5, alteration in mental status, systolic blood pressure ≤90 mm Hg, and age ≥65 years [5].

2.3. Study Endpoint

The primary endpoint was to evaluate whether the PTAR measured in the ED was an early predictor of ICU admission and mortality for UGIB. If the PTAR was a predictor, the optimal cutoff values that predict ICU admission and mortality would be calculated. The predictive performance was also compared against the traditionally used Rockall score, GBS, and AIMS65 scores.

The indication for ICU admission could not be generalized; therefore, a priority model was used to establish admission criteria [16]. The criteria for ICU admission were the application of a mechanical ventilator, hemodynamic monitoring, or the clinician’s decision according to the patient’s condition. Patients requiring intensive care and monitoring, receiving ventilator treatment or intravenous cardiovascular medications, with respiratory failure requiring ventilation after surgery, or requiring invasive monitoring were prioritized for ICU admission. Patients who needed immediate treatment at any time during intensive monitoring and those with a chronic disease that could rapidly develop into an internal or surgical disease were secondary priorities. The tertiary priorities were patients with an underlying or acute disease that is difficult to expect and those who require intensive treatment to alleviate acute disease but have limited eligibility for endotracheal intubation or cardiopulmonary resuscitation. The fourth priority is not appropriate for ICU admission [16].

2.4. Statistical Analyses

Continuous data are presented as means with standard deviations or medians (interquartile ranges) and analyzed using normality tests. The normality of data distribution was assessed using the Shapiro–Wilk test. Continuous data were analyzed using Student’s t-test or the Mann–Whitney U test, as appropriate. Categorical variables are presented as counts and percentages and were analyzed using the chi-square test or Fisher’s exact test, as appropriate. Univariate and multivariate logistic regression analyses were performed to assess the influencing factors of ICU admission and mortality. Significant variables in the univariate logistic regression analysis (those with a -value <0.2) were entered into the multivariable logistic regression analysis. To compare the predictive capability of the PTAR with that of previous risk stratification methods, receiver-operating characteristic curves were created using the optimal cutoff values determined using the Youden Index. All statistical analyses were performed using SPSS ver. 23 (IBM, New York, NY) and MedCalc Statistical Software version 17.5.3 (MedCalc Software, Ostend, Belgium). Statistical significance was set at .

3. Results

3.1. Patient Characteristics

Among the 520 patients initially identified, a patient who was aged <19 years was excluded (Figure 1). Finally, 519 patients were included in the analysis: 137 (26.4%) had variceal bleeding, 188 (36.2%) had ulcer bleeding, and 194 (37.4%) had other causes of UGIB. Other causes include Mallory-Weiss tear, gastric cancer bleeding, angiodysplasia, and gastric erosion. In this study, all patients with nonvariceal and variceal bleeding were included. Patient characteristics are shown in Table 1.

3.2. Comparison between ICU and Non-ICU Patients

In total, 163/519 patients were admitted to the ICU. Compared with the non-ICU group, the ICU group showed significantly lower systolic blood pressure (106 mmHg vs 121 mmHg, ), hemoglobin count (8.2 g/dL [range, 2.9–18.1 g/dL] vs 10.4 g/dL [range, 3.6–17.5 g/dL], ), and platelet count (164,000 [range, 19,000–724,000] vs 214,000 [range, 11,000–776,000], ). Furthermore, the ICU group showed significantly higher levels of blood urea nitrogen (33.9 mg/dL [range, 6.5–138.3 mg/dL] vs 30.1 mg/dL [range, 6.2–184.3 mg/dL], ) and creatinine (1.18 mg/dL [range, 0.50–10.61 mg/dL] vs 0.96 mg/dL [range, 0.33–19.61 mg/dL], ). The median PT-INR was higher in the ICU group than in the non-ICU group (1.26 [range, 0.86–5.49] vs 1.08 [0.75–6.63], ). Meanwhile, the median albumin level was lower in the ICU group (3.1 g/dL [range, 1.1–5.6 g/dL] vs 3.7 g/dL [range, 1.7–5.8 g/dL], ).

3.3. Comparison between Survival Discharge and Mortality

In total, 35 patients died (Table 1). The mortality group showed significantly lower median systolic blood pressure in the ED (100 mmHg [range, 53–254 mmHg] vs. 117 mmHg [range, 53–222 mmHg], ) and the hemoglobin level (7.7 g/dL [range, 2.9–14.8 g/dL] vs 9.6 g/dL [range, 2.9–18.1 g/dL], ) and a significantly higher creatinine level (1.5 mg/dL [range, 0.53–10.61 mg/dL] vs 0.98 mg/dL [range, 0.33–19.61 mg/dL], ). The median PT-INR was higher in the nonsurvivor group than in the survivor group (1.50 [range, 0.95–6.63] vs 1.10 [0.75–4.55], ). Meanwhile, the nonsurvivor group showed lower albumin levels ().

3.4. Influencing Factors of ICU Admission

The logistic regression analysis of the factors associated with ICU admission is shown in Table 2. The crude odds ratio (OR) of the PTAR was 40.943 (95% confidence interval [CI], 12.856–130.393), while that of the pre-endoscopy Rockall score, complete Rockall score, GBS, and AIMS65 score was 1.365 (95% CI, 1.194–1.562), 1.390 (95% CI, 1.250–1.546), 1.156 (95% CI, 1.100–1.214), and 1.732 (95% CI, 1.447–2.074), respectively. Univariate logistic regression analysis showed that systolic blood pressure, comorbidities, hemoglobin, and platelet count with a -value <0.2 were significant influencing variables. Thus, these factors, along with age, sex, systolic blood pressure, comorbidities, hemoglobin, and platelet count, were entered into multivariate regression analysis. The adjusted OR (aOR) of the PTAR was 8.376 (2.722–25.774), while the aORs of the complete Rockall score and AIMS65 score were 1.307 (1.102–1.549) and 1.699 (1.318–2.192), respectively. Meanwhile, the aORs of the pre-endoscopy Rockall score and GBS were not significant.

3.5. Influencing Factors of Mortality

In logistic regression analysis of influencing factors of mortality (Table 2), the crude OR of the PTAR was 31.525 (11.379–87.340). Meanwhile, the crude ORs of the pre-endoscopy Rockall score, complete Rockall score, GBS, and AIMS65 score were 1.877 (1.421–2.478), 1.631 (1.309–2.031), 1.165 (1.057–1.283), and 2.335 (1.744–3.127), respectively. Univariate logistic regression analysis showed that systolic blood pressure, comorbidities, and hemoglobin were significant factors. Thus, these factors were entered into multivariate regression analysis, along with age, sex, systolic blood pressure, comorbidities, and hemoglobin. The aOR of the PTAR was 27.846 (8.701–89.116). The aOR of the AIMS65 score was 2.154 (1.473–3.149). The aORs of the Rockall score (pre-endoscopy) was 1.647 (1.048–2.589). The aORs of the complete Rockall score and GBS were not significant.

3.6. Predictive Factors of ICU Admission and Mortality

Tables 3 and 4 show the optimal cutoff values and diagnostic accuracies of the PTAR, GBS, AIMS65 score, pre-endoscopy Rockall score, and complete Rockall score. Cutoff values of >0.320 (area under the curve [AUC]: 0.720, 95% CI: 0.679–0.758) and >0.358 (AUC: 0.816, 95% CI: 0.780–0.849) for the PTAR were predictive of ICU admission and mortality, respectively. These AUCs were higher than those for other methods of risk stratification. The sensitivity of the PTAR for admission to the ICU was 74.23 (95% CI: 66.8–80.8), and the specificity was 58.43 (95% CI: 53.1–63.6). The sensitivity of the PTAR for mortality was 85.71 (95% CI: 69.7–95.2), and the specificity was 64.88 (95% CI: 60.4–69.1). With regard to AUC values, there was a trend suggesting that PTAR seemed more accurate than the GBS, AIMS65 score, and Rockall score (pre-endoscopy) in ICU admission, and there was a trend suggesting that PTAR seemed more accurate than GBS in terms of mortality (Supplementary Tables F61 and F62).

4. Discussion

Current prognostic measures for UGIB are difficult to apply in early ED settings. This study found that the PTAR measured in the ED is an independent factor related to ICU admission and mortality in patients with UGIB. The PTAR had higher predictive capability than the conventional scoring method for predicting prognosis in the ED (i.e., the Rockall score, AIMS65 score, and GBS). An abnormally elevated PTAR was associated with ICU admission and mortality, thus providing a useful marker for the early prediction of prognosis in patients with UGIB.

The Glasgow–Blatchford scoring system, which has been validated as an accurate tool, is one of the most commonly used tools for assessing the severity of early UGIB [14]. The Rockall score, which includes both pre-and post-endoscopic components, has a high predictive capability for mortality [17]. However, because it requires several components, the Rockall score may be challenging to use in the ED [18]. The AIMS65 score was also identified as a good predictive factor for long-term hospitalization and in-hospital mortality. In patients with cirrhosis and UGIB, the AIMS65 score correlated with the length of hospitalization in variceal bleeding [19]. In a previous study, AIMS65, GBS, and Rockall scores were similar in predicting in-hospital mortality (AUC: 0.760 vs 0.780 vs 0.780, respectively) [4]. On the other hand, in a study with a sample size of 424, AIMS65 scores (AUC 0.80) were a better predictor of in-hospital mortality than GBS (AUC 0.76) [3]. In our study, the AUC of AIMS65 was 0.764, higher than the Rockall scores and GBS. In a previous study, the AUC of AIMS65 was higher than GBS and pre-endoscopy Rockall scores, the complete Rockall score for ICU admission (AUC: 0.740 vs 0.700 vs 0.620 vs 0.710) [3]. In our study, the AUC for ICU admission was lower than that reported in previous studies, and the complete Rockall score was higher than the GBS, AIMS65, and pre-endoscopy Rockall scores (AUC 0.670 vs 0.653 vs 0.656 vs 0.617, respectively). This difference may be due to different patient characteristics and ICU admission criteria. Hemoglobin levels have also been used in several studies [13]. The hemoglobin level was linked to favorable outcomes on outpatient follow-up in a previous study [20]. Although the threshold differs among studies, a lower hemoglobin level generally indicates a higher probability of endoscopy before hemodynamic instability and predicts the need for intervention to prevent additional or delayed bleeding [6, 21]. Serum albumin can also be used for risk stratification in patients with UGIB [22, 23].

Low albumin levels may be associated with malnutrition, asymptomatic liver disease, or other chronic diseases; thus, they are also inevitably associated with mortality [23]. A history of any critical disease alters albumin distribution [24], particularly in the rate at which proteins are synthesized and broken down [25]. Coagulopathy frequently occurs in patients with severe disease, and an increase in the PT-INR has been used to predict mortality [26]. Previous studies used the PTAR to evaluate liver function after liver resection in patients with hepatocellular carcinoma [8] and sepsis. The PTAR was also found to have a comparative predictive capability to the Sequential Organ Failure Assessment score for critically ill patients [10]. Another study also reported the usefulness of the PTAR for evaluating the prognosis and 30-day adverse outcomes in patients with liver disease [27].

To the best of our knowledge, our study is the first to investigate the usefulness of the PTAR in predicting the prognosis of patients with UGIB. Explanatory power in ICU admission was higher than that in the other scoring systems. The AUC for mortality was 0.816, which was also higher than that of the other scoring systems. Based on previous findings that the PTAR is related to liver disease, the PTAR can be easily used to predict the prognosis of UGIB patients in the emergency department. However, this study also has some limitations. First, some data may have been omitted because of the retrospective nature of the study. Patients with incomplete laboratory tests were excluded in this study, and patients on warfarin and those with known cirrhosis were not included in the studied subjects, which is a limitation of the retrospective study and is likely to affect the results. Second, the sample size was small because this study was conducted at the ED of a single university tertiary hospital. Third, the time from the symptom onset to ED arrival may affect the PTAR value, but this was not evaluated. Fourth, the MELD score and Child-Pugh score used in patients with liver cirrhosis and variceal bleeding were not calculated or evaluated. Fifth, indications for ICU admission may vary depending on the institution, meaning that predictions for ICU admission may be different among hospitals, depending on their clinical capability and resources. Finally, the rebleeding risk was not evaluated. Therefore, these limitations may be considered for future studies, including the validation process.

5. Conclusions

The PTAR measured in the ED is an independent factor related to ICU admission and mortality in patients with UGIB. Thus, the PTAR can be applied as a risk stratification marker for UGIB in the early emergency setting.

Data Availability

Data cannot be shared to the public because of institutional and national data policy restrictions. Data can be made available to researchers who meet the criteria for access to confidential data.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Supplementary Materials

Supplement Table 1. Pairwise comparison of receiver-operating characteristic (ROC) curves for ICU admission. Supplement Table 2. Pairwise comparison of receiver-operating characteristic (ROC) curves for mortality (Supplementary Materials)

References

D. V. Balaban, V. Strâmbu, B. G. Florea, A. R. Cazan, M. Brătucu, and M. Jinga, “Predictors for in-hospital mortality and need for clinical intervention in upper GI bleeding: a 5-year observational study,” Chirurgia, vol. 109, no. 1, pp. 48–54, 2014.
View at: Google Scholar
K. Oakland, “Changing epidemiology and etiology of upper and lower gastrointestinal bleeding,” Best Practice & Research. Clinical Gastroenterology, pp. 42-43, 2019, 101610.
View at: Publisher Site | Google Scholar
M. Robertson, A. Majumdar, R. Boyapati et al., “Risk stratification in acute upper GI bleeding: comparison of the AIMS65 score with the Glasgow-Blatchford and Rockall scoring systems,” Gastrointestinal Endoscopy, vol. 83, no. 6, pp. 1151–1160, 2016.
View at: Publisher Site | Google Scholar
J. G. Martínez-Cara, R. Jiménez-Rosales, M. Úbeda-Muñoz, M. L. de Hierro, J. de Teresa, and E. Redondo-Cerezo, “Comparison of AIMS65, Glasgow-Blatchford score, and Rockall score in a European series of patients with upper gastrointestinal bleeding: performance when predicting in-hospital and delayed mortality,” United European Gastroenterology Journal, vol. 4, no. 3, pp. 371–379, 2016.
View at: Publisher Site | Google Scholar
R. B. Thandassery, M. Sharma, A. K. John, K. M. Al-Ejji, H. Wani, K. Sultan et al., “Clinical application of AIMS65 scores to predict outcomes in patients with upper gastrointestinal hemorrhage,” Clin Endosc, vol. 48, no. 5, pp. 380–384, 2015.
View at: Publisher Site | Google Scholar
F. D. Srygley, C. J. Gerardo, T. Tran, and D. A. Fisher, “Does this patient have a severe upper gastrointestinal bleed,” JAMA, vol. 307, no. 10, pp. 1072–1079, 2012.
View at: Publisher Site | Google Scholar
K. R. Lee, S. O. Park, S. Y. Kim et al., “Red cell distribution width as a novel marker for predicting high-risk from upper gastro-intestinal bleeding patients,” PLoS One, vol. 12, no. 11, article e0187158, 2017.
View at: Publisher Site | Google Scholar
K. Haruki, H. Shiba, N. Saito et al., “Risk stratification using a novel liver functional reserve score of combination prothrombin time-international normalized ratio to albumin ratio and albumin in patients with hepatocellular carcinoma,” Surgery, vol. 164, no. 3, pp. 404–410, 2018.
View at: Publisher Site | Google Scholar
F. Gao, M. X. Cai, M. T. Lin et al., “Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis,” European Journal of Gastroenterology & Hepatology, vol. 31, no. 7, pp. 824–831, 2019.
View at: Publisher Site | Google Scholar
S. Wang, S. Ding, H. Luo, and X. Chai, “International normalized ratio to albumin ratio (PTAR): an objective risk stratification tool in patients with sepsis,” Int J Gen Med, vol. Volume 14, pp. 1829–1841, 2021.
View at: Publisher Site | Google Scholar
K. R. Palmer, “Non-variceal upper gastrointestinal haemorrhage: guidelines,” Gut, vol. 51, suppl 4, pp. iv1–iv6, 2002.
View at: Publisher Site | Google Scholar
A. K. Kamboj, P. Hoversten, and C. L. Leggett, “Upper gastrointestinal bleeding: etiologies and management,” Mayo Clinic Proceedings, vol. 94, no. 4, pp. 697–703, 2019.
View at: Publisher Site | Google Scholar
S. Monteiro, T. C. Gonçalves, J. Magalhães, and J. Cotter, “Upper gastrointestinal bleeding risk scores: who, when and why,” World Journal of Gastrointestinal Pathophysiology, vol. 7, no. 1, pp. 86–96, 2016.
View at: Publisher Site | Google Scholar
K. Chatten, H. Purssell, A. K. Banerjee, S. Soteriadou, and Y. Ang, “Glasgow Blatchford score and risk stratifications in acute upper gastrointestinal bleed: can we extend this to 2 for urgent outpatient management,” Clinical Medicine, vol. 18, no. 2, pp. 118–122, 2018.
View at: Publisher Site | Google Scholar
A. Shahrami, S. Ahmadi, and S. Safari, “Full and modified Glasgow-Blatchford bleeding score in predicting the outcome of patients with acute upper gastrointestinal bleeding; a diagnostic accuracy study,” Emergy, vol. 6, no. 1, article e31, 2018.
View at: Google Scholar
D. W. Chang, D. Dacosta, and M. F. Shapiro, “Priority levels in medical intensive care at an academic public hospital,” JAMA Internal Medicine, vol. 177, no. 2, pp. 280-281, 2017.
View at: Publisher Site | Google Scholar
T. A. Rockall, R. F. Logan, H. B. Devlin, and T. C. Northfield, “Risk assessment after acute upper gastrointestinal haemorrhage,” Gut, vol. 38, no. 3, pp. 316–321, 1996.
View at: Publisher Site | Google Scholar
N. Custovic, A. Husic-Selimovic, N. Srsen, and D. Prohic, “Comparison of Glasgow-Blatchford score and Rockall score in patients with upper gastrointestinal bleeding,” Medical Archives, vol. 74, no. 4, pp. 270–274, 2020.
View at: Publisher Site | Google Scholar
V. Gaduputi, M. Abdulsamad, H. Tariq et al., “Prognostic value of AIMS65 score in cirrhotic patients with upper gastrointestinal bleeding,” Gastroenterology Research and Practice, vol. 2014, Article ID 787256, 8 pages, 2014.
View at: Publisher Site | Google Scholar
J. M. Lee, E. S. Kim, H. J. Chun et al., “Discharge hemoglobin and outcome in patients with acute non-variceal upper gastrointestinal bleeding,” Endoscopy International Open, vol. 4, no. 8, pp. E865–E869, 2016.
View at: Publisher Site | Google Scholar
M. Tomizawa, F. Shinozaki, R. Hasegawa et al., “Low hemoglobin levels are associated with upper gastrointestinal bleeding,” Biomedical Reports, vol. 5, no. 3, pp. 349–352, 2016.
View at: Publisher Site | Google Scholar
J. A. González-González, G. Vázquez-Elizondo, R. Monreal-Robles et al., “Hypoalbuminemia in the outcome of patients with non-variceal upper gastrointestinal bleeding,” Revista de Gastroenterología de México, vol. 81, no. 4, pp. 183–189, 2016.
View at: Publisher Site | Google Scholar
C. F. Tung, W. K. Chow, C. S. Chang, Y. C. Peng, and W. H. Hu, “The prevalence and significance of hypoalbuminemia in non-variceal upper gastrointestinal bleeding,” Hepato-Gastroenterology, vol. 54, no. 76, pp. 1153–1156, 2007.
View at: Google Scholar
J. L. Vincent, J. A. Russell, M. Jacob et al., “Albumin administration in the acutely ill: what is new and where next,” Critical Care, vol. 18, no. 4, p. 231, 2014.
View at: Publisher Site | Google Scholar
J. P. Nicholson, M. R. Wolmarans, and G. R. Park, “The role of albumin in critical illness,” British Journal of Anaesthesia, vol. 85, no. 4, pp. 599–610, 2000.
View at: Publisher Site | Google Scholar
T. S. Walsh, S. J. Stanworth, R. J. Prescott, R. J. Lee, D. M. Watson, and D. Wyncoll, “Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units,” Critical Care Medicine, vol. 38, no. 10, pp. 1939–1946, 2010.
View at: Publisher Site | Google Scholar
M. Cai, Z. Han, X. He, and J. Zhang, “Usefulness of international normalized ratio to albumin ratio for evaluation of mortality in hepatitis B virus-associated decompensated cirrhosis,” BioMed Research International, vol. 2021, 2021.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Jeongwoo Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

483

Downloads

536

Citations